Jun. 14, 2023—A new grant will help support Vanderbilt's RePORT Brazil, one of an international consortium’s six regional tuberculosis research programs.
Apr. 24, 2023—Drug-resistant tuberculosis is on the rise, and novel antibacterial drugs called SPTs have potential for treating the deadly lung infection.
Feb. 23, 2023—The National Institutes of Health has awarded a five-year, $5 million grant to Vanderbilt University Medical Center for continued support of the Brazil Regional Prospective Observational Research in Tuberculosis network, or RePORT-Brazil.
Sep. 29, 2022—Vanderbilt University Medical Center is set to construct a state-of-the-art BioSafety Level 3 (BSL3) facility for research involving the COVID-19 virus, anthrax and other dangerous microorganisms.
Mar. 17, 2016—An international research team led by scientists from Vanderbilt University Medical Center has identified a genetic variant that protects people with HIV from developing active tuberculosis. The variant is near the gene encoding the infection-fighting cytokine IL-12.
Feb. 11, 2016—One small chemical change to an existing antibacterial drug results in a compound that is more effective against its target enzyme in tuberculosis, Vanderbilt researchers have discovered.
Aug. 29, 2013—Due to a national shortage of the tuberculosis (TB) test solution Tubersol, Occupational Health will temporarily suspend routine annual skin tests, effective Sept. 1, said Patricia Kinman, MSN, FNP-BC, manager of the Vanderbilt Occupational Health Clinic